CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $98,000 | -26.9% | 54,008 | -20.2% | 0.00% | – |
Q1 2021 | $134,000 | +91.4% | 67,713 | +22.3% | 0.00% | – |
Q4 2020 | $70,000 | -2.8% | 55,352 | +37.3% | 0.00% | – |
Q3 2020 | $72,000 | -74.3% | 40,307 | +20.8% | 0.00% | – |
Q2 2020 | $280,000 | +129.5% | 33,374 | +43.1% | 0.00% | – |
Q1 2020 | $122,000 | +4.3% | 23,317 | +8.7% | 0.00% | – |
Q4 2019 | $117,000 | +44.4% | 21,443 | +28.5% | 0.00% | – |
Q3 2019 | $81,000 | -38.6% | 16,691 | -13.7% | 0.00% | – |
Q2 2019 | $132,000 | -70.7% | 19,346 | -70.3% | 0.00% | – |
Q1 2019 | $451,000 | +29.6% | 65,141 | +9.1% | 0.00% | – |
Q4 2018 | $348,000 | -83.4% | 59,701 | -78.5% | 0.00% | -100.0% |
Q3 2018 | $2,096,000 | -13.3% | 277,754 | -42.0% | 0.00% | 0.0% |
Q2 2018 | $2,418,000 | +457.1% | 478,934 | +570.5% | 0.00% | – |
Q1 2018 | $434,000 | -46.7% | 71,432 | -37.8% | 0.00% | -100.0% |
Q4 2017 | $814,000 | +52.1% | 114,842 | +53.0% | 0.00% | – |
Q3 2017 | $535,000 | -43.8% | 75,072 | -50.4% | 0.00% | -100.0% |
Q2 2017 | $952,000 | +15.4% | 151,361 | +51.2% | 0.00% | 0.0% |
Q1 2017 | $825,000 | -2.4% | 100,100 | +0.1% | 0.00% | 0.0% |
Q4 2016 | $845,000 | +316.3% | 100,000 | +233.3% | 0.00% | – |
Q3 2016 | $203,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |